• FDA approves Pomalyst as first new Kaposi sarcoma treatment in 20 years

    10 days ago - By Healio

    The FDA granted accelerated approval to pomalidomide for treatment of two forms of Kaposi sarcoma.
    The approval applies to use of pomalidomide by patients with AIDS-related Kaposi sarcoma whose disease has become resistant to highly active antiretroviral therapy, or by patients with Kaposi sarcoma who are HIV-negative.
    Pomalidomide - a thalidomide analogue already approved for use with dexamethasone for treatment of certain patients with multiple myeloma - is the first new treatment option for Kaposi sarcoma in more than 20 years.
    “Patients with
    Read more ...

     

  • FDA Approves Pomalidomide for Kaposi Sarcoma

    11 days ago - By Medscape

    Pomalidomide is the first new treatment option for Kaposi sarcoma in more than 20 years; the drug is already marketed for multiple myeloma.
    FDA Approvals
    Read more ...